Introduction
Age-related volume loss in the midface is a defining
feature of facial aging, contributing to a sunken appearance, deepened
nasolabial folds, and loss of youthful contour. This process is driven by fat
pad atrophy, bone resorption, and collagen degradation. Injectable treatments
play a central role in midface restoration, with Sculptra® (poly-L-lactic acid)
and Restylane® (hyaluronic acid-based filler) being among the most widely used
options.
Although both products are effective, they differ
significantly in mechanism of action, treatment strategy, and longevity. This
article presents two real-world case studies illustrating how each injectable
performs in midface volume restoration and highlights the clinical
considerations guiding product selection.
Case Study 1: Gradual Rejuvenation with Sculptra®
Patient Profile
Marina, a 52-year-old female, presented with concerns
of progressive midface volume loss, mild skin laxity, and a chronically tired
facial appearance. She had Fitzpatrick skin type III, was a non-smoker,
reported no autoimmune disease, and was in good general health.
Treatment Plan
Given Marina’s preference for subtle, progressive
rejuvenation and her willingness to undergo staged treatment, Sculptra® was
selected for its collagen-stimulating properties. The treatment protocol
consisted of three sessions spaced four weeks apart, using a total of five
vials distributed in a 2-2-1 regimen.
Procedure and Injection Technique
Sculptra® was reconstituted according to manufacturer
guidelines and injected using a cannula-based fan technique. Product placement
focused on the deep dermis and superficial subcutaneous layer of the malar
region and lateral cheek to enhance structural support. Post-procedure, the
patient was instructed to perform the standard massage protocol (five minutes,
five times daily, for five days) to optimize product dispersion.
Results and Outcome
Initial improvement became visible approximately six
weeks after the first session, with continued enhancement over the following
three months. Outcomes included restored cheek fullness, improved skin texture,
and a subtle lifting effect of the lower face. Results appeared natural,
without overcorrection. Only mild, transient swelling was reported, resolving
within days.
Case Study 2: Immediate Midface Volume
Restoration with Restylane®
Patient Profile
Eleni, a 45-year-old female, presented with moderate
midface deflation and pronounced nasolabial folds. She expressed a desire for
immediate improvement with minimal downtime. Her Fitzpatrick skin type was II,
with no significant medical comorbidities or prior filler treatments.
Treatment Plan
Restylane® was selected due to its hyaluronic acid
composition, offering immediate volumization and structural support. A
single-session treatment plan was designed, using 2 mL of product to restore
midface projection and soften nasolabial folds.
Procedure and Injection Technique
The filler was injected using a combination of bolus
and linear threading techniques, placed supraperiosteally in the malar apex and
deep subcutaneous plane. Careful anatomical mapping ensured safe placement
while preserving natural facial dynamics.
Results and Outcome
Immediate volume restoration was observed post-treatment, with enhanced cheek projection and improved midface contour. Nasolabial folds appeared softened, and facial proportions were visibly balanced. Mild bruising occurred at one injection site but resolved within one week. Patient satisfaction was high due to the instant aesthetic improvement.
Comparative Discussion
These case studies illustrate two distinct yet
complementary approaches to midface rejuvenation. Sculptra® functions as a
biostimulator, inducing neocollagenesis and delivering progressive,
long-lasting improvement in tissue quality and volume. It is particularly
suitable for patients with generalized volume loss, skin thinning, or those
seeking regenerative outcomes.
In contrast, Restylane® provides immediate volumetric
correction and structural support, making it ideal for patients prioritizing
instant results or addressing localized midface deflation. While hyaluronic
acid fillers offer reversibility and predictability, their effects are
temporary compared to collagen-stimulating agents.
Product selection should be individualized, factoring in patient age, degree of volume loss, skin quality, treatment goals, and willingness to commit to staged therapy.
Conclusion
Both Sculptra® and Restylane® are effective tools for midface volume restoration when used appropriately. Biostimulatory treatments favor long-term regeneration and gradual enhancement, while hyaluronic acid fillers excel in immediate contour correction. A tailored, anatomy-driven approach ensures optimal outcomes and high patient satisfaction.
References
1.
Fitzgerald, R., et al. Collagen
stimulation with poly-L-lactic acid: Mechanisms and clinical outcomes. Journal of Cosmetic Dermatology, 2020.
2.
Goldberg, D.J., et al. Poly-L-lactic
acid for facial volume restoration: A multicenter study. Dermatologic Surgery, 2019.
3.
Narins, R.S., et al. Hyaluronic acid
fillers: Safety, efficacy, and injection techniques. Plastic and Reconstructive Surgery, 2018.
4.
Flynn, T.C. Anatomical considerations
in midface volumization. Aesthetic Surgery Journal, 2016.
5.
Sundaram, H., et al. Global
aesthetics consensus: Midface volume restoration strategies. Journal of Aesthetic and
Reconstructive Surgery, 2021.